Koyfin Home > Directory > Health Care > Kezar Life Sciences Inc > Cash from Financing Activities

Kezar Life Sciences Inc Cash from Financing Activities Chart (KZR)

Kezar Life Sciences Inc annual/quarterly Cash from Financing Activities from 2017 to 2020.
  • Kezar Life Sciences Inc Cash from Financing Activities for the quarter ending June 06, 2020 was $44m a 99.98% increase of 44m year over year
  • Kezar Life Sciences Inc Cash from Financing Activities for the last 12 months ending June 06, 2020 was $97m a 99.80% increase of 97m year over year
  • Kezar Life Sciences Inc Annual Cash from Financing Activities for 2019 was $0m a -28,544.49% decrease of -78m from 2018
  • Kezar Life Sciences Inc Annual Cash from Financing Activities for 2018 was $78m a 36.14% increase of 28m from 2017
  • Kezar Life Sciences Inc Annual Cash from Financing Activities for 2017 was $50m a 99.93% increase of 50m from 2016
Other Cash Flow Metrics:
  • Kezar Life Sciences Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-5m a 52.69% decrease of -2m year over year
  • Kezar Life Sciences Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-4m
View Chart On Koyfin

Quarterly KZR Cash from Financing Activities Data

06/2020$44m
03/2020$53m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$-1m
06/2018$79m
03/2018$0m

Annual KZR Cash from Financing Activities Data

2019$0m
2018$78m
2017$50m
2016$0m